Sunday, April 2, 2017

stardem : reported that Zika vaccine test moves to next stage with more than 2,000 volunteers in U.S., abroad

Let us know what's going on! We're always interested in hearing about news in our community.


U.S. enrolling volunteers in Zika vaccine test


U.S. enrolling volunteers in Zika vaccine test
U.S. health officials are enrolling volunteers for critical next-stage testing of an experimental vaccine to protect against Zika, the mosquito-borne virus that can cause devastating birth defects in pregnant women. The U.S. risk has largely been to travelers, although mosquitoes spread the virus in parts of southern Florida and Texas last year. National Institutes of Health researchers aim to enroll at least 2,400 people in Texas, Florida, Puerto Rico and five at-risk countries: Brazil, Mexico, Panama, Costa Rica and Peru. Zika caused a large outbreak in parts of Latin America and the Caribbean last year. The first volunteer was vaccinated Wednesday at Baylor College of Medicine.

US enrolls volunteers in large test of possible Zika vaccine

The NIH also is testing the safety of some more traditional Zika vaccine candidates, but the easier-to-make DNA vaccine was the first ready to advance to this second stage of human testing. All the volunteers will be tracked for nearly two years to see if the vaccine really protects against Zika infection. Pregnant women can't receive the experimental shots but women of child-bearing age can enroll. U.S. health officials have begun enrolling volunteers for critical next-stage testing of an experimental vaccine to protect against Zika, the mosquito-borne virus that can cause devastating birth defects in pregnant women. (AP Photo/LM Otero, File)U.S. health officials have begun enrolling volunteers for critical next-stage testing of an experimental vaccine to protect against Zika, the mosquito-borne virus that can cause devastating birth defects in pregnant women.


collected by :Lucy William
To follow all the new news about

VIRUSES and INFECTIONS

No comments:

Post a Comment